PLUREXA
Live / Registered — Registered (as of 17 Sept 2024)
What this means for you
Registered since 17 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97692503
- Registration number
- 7509068
- Mark type
- Stylized text
- Filed
- 26 Nov 2022
- Published for opposition
- 10 Oct 2023
- Registered
- 17 Sept 2024
Goods and services
- Class 001 — Chemicals: Cells for scientific and research use; Cells for scientific, laboratory or medical research; Stem cells other than for medical or veterinary purposes; Stem cells, other than for medical or veterinary purposes; Stem cells for research or scientific purposes; Stem cells for research purposes
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of new products for others; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development services in the field of antibodies; Research in the field of cell engineering technology; Research in the field of gene editing technology; Biochemical research; Biochemical research and analysis; Biochemical research and development; Biological research; Biological research and analysis; Biomedical research services; Biotechnology research; Cell culture services for scientific and research purposes, for others; Chemical research; Chemical research and analysis; Chemical research services; Consulting services in the field of pharmaceutical research and development; Culturing of cells for others for scientific research purposes; Genetic testing for scientific research purposes; Pharmaceutical research and development; Pharmaceutical research services; Physics research; Product research; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Scientific research; Scientific research and development; Scientific research consulting; Scientific research for medical purposes in the area of cancerous diseases; Scientific research in the field of genetics and genetic engineering; Stem cell research services; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Owner
- Plurexa LLC, Seattle, WA, US
- Plurexa LLC, Seattle, WA, US
- Plurexa LLC, Seattle, WA, US
Prosecution history
- 17 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 09 Aug 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Aug 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Jun 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 04 May 2024 — USE AMENDMENT FILED
- 07 Jun 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 May 2024 — TEAS STATEMENT OF USE RECEIVED
- 05 Dec 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Oct 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Oct 2023 — PUBLISHED FOR OPPOSITION
- 20 Sept 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Sept 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Sept 2023 — ASSIGNED TO EXAMINER
- 19 Dec 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED